American Journal of Kidney Diseases, ISSN 0272-6386, 2014, Volume 64, Issue 5, pp. 696 - 705
Background The 2009 KDIGO (Kidney Disease: Improving Global Outcomes) chronic kidney disease–mineral and bone disorder clinical practice guideline suggests...
Nephrology | calcium | 25-hydroxyvitamin D | Cholecalciferol | vitamin D | nutritional vitamin D | vascular calcification | fetuin A | parathyroid hormone (PTH) | vitamin D repletion | aortic calcification score | vitamin D deficiency | clinical practice guidelines | fibroblast growth factor 23 (FGF-23) | falls | calcitriol | 1,25-dihydroxyvitamin D | bone fracture | hemodialysis | Index Words Cholecalciferol | calcium parathyroid hormone (PTH) | bone fracture falls | fetuina | HIGH-DOSE CHOLECALCIFEROL | EXTRA-RENAL PRODUCTION | MUSCLE STRENGTH | D SUPPLEMENTATION | VITAMIN-D DEFICIENCY | FAILURE | DIALYSIS PATIENTS | UROLOGY & NEPHROLOGY | MINERAL METABOLISM | CHRONIC KIDNEY-DISEASE | Prospective Studies | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Renal Dialysis - methods | Male | Cholecalciferol - blood | Vitamin D - blood | Renal Insufficiency, Chronic - blood | Renal Insufficiency, Chronic - therapy | Cholecalciferol - administration & dosage | Female | Aged | Longitudinal Studies
Nephrology | calcium | 25-hydroxyvitamin D | Cholecalciferol | vitamin D | nutritional vitamin D | vascular calcification | fetuin A | parathyroid hormone (PTH) | vitamin D repletion | aortic calcification score | vitamin D deficiency | clinical practice guidelines | fibroblast growth factor 23 (FGF-23) | falls | calcitriol | 1,25-dihydroxyvitamin D | bone fracture | hemodialysis | Index Words Cholecalciferol | calcium parathyroid hormone (PTH) | bone fracture falls | fetuina | HIGH-DOSE CHOLECALCIFEROL | EXTRA-RENAL PRODUCTION | MUSCLE STRENGTH | D SUPPLEMENTATION | VITAMIN-D DEFICIENCY | FAILURE | DIALYSIS PATIENTS | UROLOGY & NEPHROLOGY | MINERAL METABOLISM | CHRONIC KIDNEY-DISEASE | Prospective Studies | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Renal Dialysis - methods | Male | Cholecalciferol - blood | Vitamin D - blood | Renal Insufficiency, Chronic - blood | Renal Insufficiency, Chronic - therapy | Cholecalciferol - administration & dosage | Female | Aged | Longitudinal Studies
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 05/2010, Volume 91, Issue 5, pp. 1255 - 1260
Background: To our knowledge, no rigorously designed clinical trials have evaluated the relation between vitamin D and physician-diagnosed seasonal influenza....
CYTOKINES | NUTRITION & DIETETICS | VIRUS | PROTEIN | NUTRITION EXAMINATION SURVEY | SAFETY | 3RD NATIONAL-HEALTH | ASTHMA | DEFENSINS | INFECTION | CHILDREN | Japan - epidemiology | Body Weight | Double-Blind Method | Humans | Influenza, Human - epidemiology | Male | Risk | Patient Selection | Cholecalciferol - administration & dosage | Influenza A virus | Cholecalciferol - therapeutic use | Adolescent | Placebos | Body Height | Female | Cholecalciferol - adverse effects | Child | Dietary Supplements | Influenza, Human - prevention & control | Prevention | Vitamin D | Influenza | Elementary school students | Calcifediol | Research | Alfacalcidol | Health aspects | Risk factors
CYTOKINES | NUTRITION & DIETETICS | VIRUS | PROTEIN | NUTRITION EXAMINATION SURVEY | SAFETY | 3RD NATIONAL-HEALTH | ASTHMA | DEFENSINS | INFECTION | CHILDREN | Japan - epidemiology | Body Weight | Double-Blind Method | Humans | Influenza, Human - epidemiology | Male | Risk | Patient Selection | Cholecalciferol - administration & dosage | Influenza A virus | Cholecalciferol - therapeutic use | Adolescent | Placebos | Body Height | Female | Cholecalciferol - adverse effects | Child | Dietary Supplements | Influenza, Human - prevention & control | Prevention | Vitamin D | Influenza | Elementary school students | Calcifediol | Research | Alfacalcidol | Health aspects | Risk factors
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 09/2017, Volume 107, pp. 78 - 86
Poly(lactic- -glycolic acid) microspheres loaded with cholecalciferol (CL), more bioactive form of vitamin D was developed as an injectable controlled drug...
Microspheres | Tocopherol succinate | PLGA | Vitamin D | Stabilizer | Cholecalciferol | VITAMIN-D | SOLVENT EXTRACTION/EVAPORATION | RESIDUAL SOLVENTS | ENCAPSULATION | MECHANISMS | POLY(D,L-LACTIDE-CO-GLYCOLIDE) | NANOPARTICLES | PLGA MICROPARTICLES | POLYMERIC MICROSPHERES | PHARMACOLOGY & PHARMACY | MORPHOLOGY | alpha-Tocopherol - administration & dosage | Lactic Acid - chemistry | Cholecalciferol - chemistry | Delayed-Action Preparations - chemistry | Cholecalciferol - blood | Injections, Intramuscular | Rats, Sprague-Dawley | Cholecalciferol - pharmacokinetics | Delayed-Action Preparations - administration & dosage | Drug Delivery Systems | Lactic Acid - pharmacokinetics | Animals | Cholecalciferol - administration & dosage | Polyglycolic Acid - pharmacokinetics | Polyglycolic Acid - chemistry | Delayed-Action Preparations - pharmacokinetics | Drug Liberation | alpha-Tocopherol - pharmacokinetics | Lactic Acid - administration & dosage | Polyglycolic Acid - administration & dosage | alpha-Tocopherol - chemistry | Drugs | Drug delivery systems | Tocopherols | Calcifediol | Alfacalcidol | Polymers | Vehicles
Microspheres | Tocopherol succinate | PLGA | Vitamin D | Stabilizer | Cholecalciferol | VITAMIN-D | SOLVENT EXTRACTION/EVAPORATION | RESIDUAL SOLVENTS | ENCAPSULATION | MECHANISMS | POLY(D,L-LACTIDE-CO-GLYCOLIDE) | NANOPARTICLES | PLGA MICROPARTICLES | POLYMERIC MICROSPHERES | PHARMACOLOGY & PHARMACY | MORPHOLOGY | alpha-Tocopherol - administration & dosage | Lactic Acid - chemistry | Cholecalciferol - chemistry | Delayed-Action Preparations - chemistry | Cholecalciferol - blood | Injections, Intramuscular | Rats, Sprague-Dawley | Cholecalciferol - pharmacokinetics | Delayed-Action Preparations - administration & dosage | Drug Delivery Systems | Lactic Acid - pharmacokinetics | Animals | Cholecalciferol - administration & dosage | Polyglycolic Acid - pharmacokinetics | Polyglycolic Acid - chemistry | Delayed-Action Preparations - pharmacokinetics | Drug Liberation | alpha-Tocopherol - pharmacokinetics | Lactic Acid - administration & dosage | Polyglycolic Acid - administration & dosage | alpha-Tocopherol - chemistry | Drugs | Drug delivery systems | Tocopherols | Calcifediol | Alfacalcidol | Polymers | Vehicles
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 12/2013, Volume 98, Issue 12, pp. 4845 - 4851
Context: Guidelines have suggested that obese adults need 2 to 3 times more vitamin D than lean adults to treat vitamin D deficiency, but few studies have...
Single-Blind Method | Humans | Middle Aged | Male | Parathyroid Hormone - blood | Obesity - blood | Nebraska | Calcium - blood | Cholecalciferol - administration & dosage | Obesity - urine | Cholecalciferol - therapeutic use | Adult | Female | Cholecalciferol - adverse effects | Dietary Supplements - adverse effects | Seasons | Vitamin D Deficiency - etiology | Body Mass Index | Calcifediol - blood | Obesity - physiopathology | Calcium - urine | Obesity - metabolism | Vitamin D Deficiency - prevention & control | Cholecalciferol - metabolism | Models, Biological | Calcifediol - metabolism | Kinetics | Recommended Dietary Allowances | Cohort Studies
Single-Blind Method | Humans | Middle Aged | Male | Parathyroid Hormone - blood | Obesity - blood | Nebraska | Calcium - blood | Cholecalciferol - administration & dosage | Obesity - urine | Cholecalciferol - therapeutic use | Adult | Female | Cholecalciferol - adverse effects | Dietary Supplements - adverse effects | Seasons | Vitamin D Deficiency - etiology | Body Mass Index | Calcifediol - blood | Obesity - physiopathology | Calcium - urine | Obesity - metabolism | Vitamin D Deficiency - prevention & control | Cholecalciferol - metabolism | Models, Biological | Calcifediol - metabolism | Kinetics | Recommended Dietary Allowances | Cohort Studies
Journal Article
Metabolism, ISSN 0026-0495, 2014, Volume 63, Issue 9, pp. 1115 - 1124
Abstract Objectives Vitamin D insufficiency is common in subjects with type 2 diabetes. Observational studies suggest that vitamin D plays a role in the...
Endocrinology & Metabolism | Vitamin D deficiency | Inflammation | Insulin pulsatility | Hyperinsulinemic euglycemic clamp | TERM TREATMENT | RAT PANCREAS | HYPOVITAMINOSIS-D | IMPAIRED GLUCOSE-TOLERANCE | RISK | BLOOD-PRESSURE | SUPPLEMENTATION | MIDDLE-AGED MEN | CALCIUM | ENDOCRINOLOGY & METABOLISM | SECRETION | C-Peptide - blood | Vitamin D Deficiency - complications | Humans | Middle Aged | Male | Vitamin D Deficiency - physiopathology | Insulin-Secreting Cells - metabolism | Cholecalciferol - administration & dosage | Cholecalciferol - therapeutic use | Diabetes Mellitus, Type 2 - immunology | Female | Seasons | Insulin Secretion | Diabetes Mellitus, Type 2 - complications | Severity of Illness Index | Calcifediol - blood | Double-Blind Method | Inflammation Mediators - blood | Insulin Resistance | Biomarkers - blood | Calcitriol - blood | Insulin-Secreting Cells - immunology | Insulin - metabolism | Cholecalciferol - metabolism | Denmark | Aged | Vitamin D Deficiency - diet therapy | Kinetics | Vitamin D Deficiency - metabolism | Dietary Supplements
Endocrinology & Metabolism | Vitamin D deficiency | Inflammation | Insulin pulsatility | Hyperinsulinemic euglycemic clamp | TERM TREATMENT | RAT PANCREAS | HYPOVITAMINOSIS-D | IMPAIRED GLUCOSE-TOLERANCE | RISK | BLOOD-PRESSURE | SUPPLEMENTATION | MIDDLE-AGED MEN | CALCIUM | ENDOCRINOLOGY & METABOLISM | SECRETION | C-Peptide - blood | Vitamin D Deficiency - complications | Humans | Middle Aged | Male | Vitamin D Deficiency - physiopathology | Insulin-Secreting Cells - metabolism | Cholecalciferol - administration & dosage | Cholecalciferol - therapeutic use | Diabetes Mellitus, Type 2 - immunology | Female | Seasons | Insulin Secretion | Diabetes Mellitus, Type 2 - complications | Severity of Illness Index | Calcifediol - blood | Double-Blind Method | Inflammation Mediators - blood | Insulin Resistance | Biomarkers - blood | Calcitriol - blood | Insulin-Secreting Cells - immunology | Insulin - metabolism | Cholecalciferol - metabolism | Denmark | Aged | Vitamin D Deficiency - diet therapy | Kinetics | Vitamin D Deficiency - metabolism | Dietary Supplements
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 12/2013, Volume 98, Issue 12, pp. 4816 - 4825
Context: Changes in serum vitamin D metabolites and calcium absorption with varying doses of oral vitamin D3 in healthy children are unknown. Objective: Our...
Indiana | Humans | African Americans | Male | Parathyroid Hormone - blood | Intestinal Absorption - ethnology | Cholecalciferol - administration & dosage | Vitamin D Deficiency - blood | Cholecalciferol - therapeutic use | Female | Calcitriol - metabolism | Child Development | Cholecalciferol - adverse effects | Dietary Supplements - adverse effects | Seasons | Child | Parathyroid Hormone - secretion | Calcifediol - blood | Double-Blind Method | European Continental Ancestry Group | Calcitriol - blood | Vitamin D Deficiency - ethnology | Vitamin D Deficiency - prevention & control | Cholecalciferol - metabolism | Models, Biological | Adolescent | Sunlight | Calcifediol - metabolism | Calcium, Dietary - metabolism | Georgia | Vitamin D Deficiency - metabolism | Endocrine Care
Indiana | Humans | African Americans | Male | Parathyroid Hormone - blood | Intestinal Absorption - ethnology | Cholecalciferol - administration & dosage | Vitamin D Deficiency - blood | Cholecalciferol - therapeutic use | Female | Calcitriol - metabolism | Child Development | Cholecalciferol - adverse effects | Dietary Supplements - adverse effects | Seasons | Child | Parathyroid Hormone - secretion | Calcifediol - blood | Double-Blind Method | European Continental Ancestry Group | Calcitriol - blood | Vitamin D Deficiency - ethnology | Vitamin D Deficiency - prevention & control | Cholecalciferol - metabolism | Models, Biological | Adolescent | Sunlight | Calcifediol - metabolism | Calcium, Dietary - metabolism | Georgia | Vitamin D Deficiency - metabolism | Endocrine Care
Journal Article
Talanta, ISSN 0039-9140, 10/2013, Volume 115, pp. 806 - 813
A simple and rapid method was developed using reversed-phase liquid chromatography (LC) with both diode array (DAD) and atmospheric pressure chemical...
LC–APCI-MS | Vitamin K (phylloquinone (K1), Menaquinone 4 (K2), Menadione (K3)) | Foods | Dispersive liquid–liquid microextraction | Vitamin D (ergocalciferol (D2), Cholecalciferol (D3)) | Menaquinone 4 (K | LC-APCI-MS Vitamin D (ergocalciferol (D | Vitamin K (phylloquinone (K | Dispersive liquid-liquid microextraction | Menadione (K | Cholecalciferol (D | CHEMISTRY, ANALYTICAL | FAT-SOLUBLE VITAMINS | QUANTIFICATION | Cholecalciferol (D-3) | Menaquinone 4 (K-2) | NUTRITIONAL SUPPLEMENTS | EXTRACTION | Menadione (K-3) | PHYLLOQUINONE VITAMIN-K-1 | POSTCOLUMN REDUCTION | Vitamin K (phylloquinone (K-1) | Vitamin D (ergocalciferol (D-2) | CHOLECALCIFEROL VITAMIN-D-3 | LC-APCI-MS | INFANT FORMULAS | MILK | Water | Ergocalciferols - analysis | Sodium Chloride | Liquid Phase Microextraction - methods | Carbon Tetrachloride | Humans | Infant Formula - chemistry | Factor Analysis, Statistical | Vitamin K 1 - analysis | 2-Propanol | Cholecalciferol - analysis | Chromatography, Reverse-Phase | Food Analysis | Reference Standards | Vegetables - chemistry | Vitamin K 3 - analysis | Spectrometry, Mass, Electrospray Ionization | Time Factors | Acetonitriles | Vitamin K 2 - analysis | Hydrogen-Ion Concentration | Methanol | Circuit components | Vitamin D | Analysis | Carbon tetrachloride | Calcifediol | Nitriles | Liquid chromatography | Alfacalcidol | Mass spectrometry
LC–APCI-MS | Vitamin K (phylloquinone (K1), Menaquinone 4 (K2), Menadione (K3)) | Foods | Dispersive liquid–liquid microextraction | Vitamin D (ergocalciferol (D2), Cholecalciferol (D3)) | Menaquinone 4 (K | LC-APCI-MS Vitamin D (ergocalciferol (D | Vitamin K (phylloquinone (K | Dispersive liquid-liquid microextraction | Menadione (K | Cholecalciferol (D | CHEMISTRY, ANALYTICAL | FAT-SOLUBLE VITAMINS | QUANTIFICATION | Cholecalciferol (D-3) | Menaquinone 4 (K-2) | NUTRITIONAL SUPPLEMENTS | EXTRACTION | Menadione (K-3) | PHYLLOQUINONE VITAMIN-K-1 | POSTCOLUMN REDUCTION | Vitamin K (phylloquinone (K-1) | Vitamin D (ergocalciferol (D-2) | CHOLECALCIFEROL VITAMIN-D-3 | LC-APCI-MS | INFANT FORMULAS | MILK | Water | Ergocalciferols - analysis | Sodium Chloride | Liquid Phase Microextraction - methods | Carbon Tetrachloride | Humans | Infant Formula - chemistry | Factor Analysis, Statistical | Vitamin K 1 - analysis | 2-Propanol | Cholecalciferol - analysis | Chromatography, Reverse-Phase | Food Analysis | Reference Standards | Vegetables - chemistry | Vitamin K 3 - analysis | Spectrometry, Mass, Electrospray Ionization | Time Factors | Acetonitriles | Vitamin K 2 - analysis | Hydrogen-Ion Concentration | Methanol | Circuit components | Vitamin D | Analysis | Carbon tetrachloride | Calcifediol | Nitriles | Liquid chromatography | Alfacalcidol | Mass spectrometry
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 11/2015, Volume 102, Issue 5, pp. 1059 - 1069
Tuberculosis, including multidrug-resistant tuberculosis (MDR-TB), is a major global health problem. Individuals with tuberculosis disease commonly exhibit...
Multidrug-resistant tuberculosis | Tuberculosis | Mycobacterium tuberculosis | Vitamin D | Randomized controlled trial | Sputum - microbiology | Tuberculosis, Pulmonary - microbiology | Antitubercular Agents - adverse effects | Vitamin D Deficiency - complications | Humans | Middle Aged | Mycobacterium tuberculosis - immunology | Male | Tuberculosis, Pulmonary - drug therapy | Patient Dropouts | Mycobacterium tuberculosis - drug effects | Tuberculosis, Pulmonary - complications | Young Adult | Sputum - immunology | Cholecalciferol - administration & dosage | Sputum - drug effects | Vitamin D Deficiency - blood | Cholecalciferol - therapeutic use | Adult | Female | Cholecalciferol - adverse effects | Dietary Supplements - adverse effects | Vitamin D Deficiency - immunology | Antitubercular Agents - therapeutic use | Calcifediol - blood | Double-Blind Method | Georgia (Republic) | Mycobacterium tuberculosis - isolation & purification | Tuberculosis, Pulmonary - immunology | Cholecalciferol - metabolism | Adolescent | Intention to Treat Analysis | Vitamin D Deficiency - diet therapy | Longitudinal Studies | Cohort Studies
Multidrug-resistant tuberculosis | Tuberculosis | Mycobacterium tuberculosis | Vitamin D | Randomized controlled trial | Sputum - microbiology | Tuberculosis, Pulmonary - microbiology | Antitubercular Agents - adverse effects | Vitamin D Deficiency - complications | Humans | Middle Aged | Mycobacterium tuberculosis - immunology | Male | Tuberculosis, Pulmonary - drug therapy | Patient Dropouts | Mycobacterium tuberculosis - drug effects | Tuberculosis, Pulmonary - complications | Young Adult | Sputum - immunology | Cholecalciferol - administration & dosage | Sputum - drug effects | Vitamin D Deficiency - blood | Cholecalciferol - therapeutic use | Adult | Female | Cholecalciferol - adverse effects | Dietary Supplements - adverse effects | Vitamin D Deficiency - immunology | Antitubercular Agents - therapeutic use | Calcifediol - blood | Double-Blind Method | Georgia (Republic) | Mycobacterium tuberculosis - isolation & purification | Tuberculosis, Pulmonary - immunology | Cholecalciferol - metabolism | Adolescent | Intention to Treat Analysis | Vitamin D Deficiency - diet therapy | Longitudinal Studies | Cohort Studies
Journal Article
British Journal of Nutrition, ISSN 0007-1145, 2/2010, Volume 103, Issue 4, pp. 549 - 555
Low serum 25-hydroxyvitamin D (25(OH)D) has been shown to correlate with increased risk of type 2 diabetes. Small, observational studies suggest an action for...
Type 2 diabetes | Vitamin D | Insulin resistance | HOMEOSTASIS MODEL ASSESSMENT | HYPOVITAMINOSIS-D | SENSITIVITY | IMPAIRED GLUCOSE-TOLERANCE | BETA-CELL FUNCTION | NUTRITION & DIETETICS | DOUBLE-BLIND | 1,25-DIHYDROXYVITAMIN D-3 | RECEPTOR GENE | SECRETION | ADIPOSE-TISSUE | Double-Blind Method | Humans | Middle Aged | Asia - ethnology | Vitamin D Deficiency - drug therapy | Vitamins - therapeutic use | Vitamins - pharmacology | Vitamin D - blood | New Zealand | Vitamin D Deficiency - ethnology | Asian Continental Ancestry Group | Insulin - metabolism | C-Reactive Protein - metabolism | Cholecalciferol - administration & dosage | Vitamin D Deficiency - blood | Cholecalciferol - therapeutic use | Adult | Female | Vitamin D - analogs & derivatives | Nutritional Status | Dietary Supplements | Insulin Secretion | Cholecalciferol - pharmacology | Insulin Resistance - ethnology | Women | Nutrition research | Dietary supplements | Clinical trials | Vitamin deficiency | Minority & ethnic groups | Clinical outcomes
Type 2 diabetes | Vitamin D | Insulin resistance | HOMEOSTASIS MODEL ASSESSMENT | HYPOVITAMINOSIS-D | SENSITIVITY | IMPAIRED GLUCOSE-TOLERANCE | BETA-CELL FUNCTION | NUTRITION & DIETETICS | DOUBLE-BLIND | 1,25-DIHYDROXYVITAMIN D-3 | RECEPTOR GENE | SECRETION | ADIPOSE-TISSUE | Double-Blind Method | Humans | Middle Aged | Asia - ethnology | Vitamin D Deficiency - drug therapy | Vitamins - therapeutic use | Vitamins - pharmacology | Vitamin D - blood | New Zealand | Vitamin D Deficiency - ethnology | Asian Continental Ancestry Group | Insulin - metabolism | C-Reactive Protein - metabolism | Cholecalciferol - administration & dosage | Vitamin D Deficiency - blood | Cholecalciferol - therapeutic use | Adult | Female | Vitamin D - analogs & derivatives | Nutritional Status | Dietary Supplements | Insulin Secretion | Cholecalciferol - pharmacology | Insulin Resistance - ethnology | Women | Nutrition research | Dietary supplements | Clinical trials | Vitamin deficiency | Minority & ethnic groups | Clinical outcomes
Journal Article
AMERICAN JOURNAL OF CLINICAL NUTRITION, ISSN 0002-9165, 06/2012, Volume 95, Issue 6, pp. 1357 - 1364
Background: Currently, there is a lack of clarity in the literature as to whether there is a definitive difference between the effects of vitamins D-2 and D-3...
CHOLECALCIFEROL | TRIALS | NUTRITION & DIETETICS | QUALITY | ERGOCALCIFEROL VITAMIN-D-2
CHOLECALCIFEROL | TRIALS | NUTRITION & DIETETICS | QUALITY | ERGOCALCIFEROL VITAMIN-D-2
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 01/2012, Volume 27, Issue 1, pp. 170 - 176
Daily vitamin D in addition to calcium supplementation reduces falls and fractures in older women. However, poor adherence to therapy is a common clinical...
FALLS | OLDER WOMEN | MUSCLE STRENGTH | MOBILITY | CHOLECALCIFEROL SUPPLEMENTATION | VITAMIN-D | PREVENTION | RISK | DENSITY | CALCIUM SUPPLEMENTATION | COMMUNITY | MEN | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | FRACTURES | Movement - drug effects | Postmenopause - blood | Life Style | Postmenopause - drug effects | Calcium - pharmacology | Drug Administration Schedule | Administration, Oral | Humans | Calcium - administration & dosage | Vitamin D - blood | Cholecalciferol - administration & dosage | Accidental Falls - prevention & control | Female | Vitamin D - analogs & derivatives | Aged | Cholecalciferol - adverse effects | Muscle Strength - drug effects | Dietary Supplements | Postmenopause - physiology | Cholecalciferol - pharmacology | Medical colleges | Vitamin D | Oncology, Experimental | Clinical trials | Calcifediol | Postmenopausal women | Research | Alfacalcidol | Diabetes | Cancer
FALLS | OLDER WOMEN | MUSCLE STRENGTH | MOBILITY | CHOLECALCIFEROL SUPPLEMENTATION | VITAMIN-D | PREVENTION | RISK | DENSITY | CALCIUM SUPPLEMENTATION | COMMUNITY | MEN | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | FRACTURES | Movement - drug effects | Postmenopause - blood | Life Style | Postmenopause - drug effects | Calcium - pharmacology | Drug Administration Schedule | Administration, Oral | Humans | Calcium - administration & dosage | Vitamin D - blood | Cholecalciferol - administration & dosage | Accidental Falls - prevention & control | Female | Vitamin D - analogs & derivatives | Aged | Cholecalciferol - adverse effects | Muscle Strength - drug effects | Dietary Supplements | Postmenopause - physiology | Cholecalciferol - pharmacology | Medical colleges | Vitamin D | Oncology, Experimental | Clinical trials | Calcifediol | Postmenopausal women | Research | Alfacalcidol | Diabetes | Cancer
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 08/2008, Volume 88, Issue 2, pp. 491S - 499S
New knowledge of the biological and clinical importance of the steroid hormone 1 alpha, 25-dihydroxyvitamin D-3 [1 alpha, 25(OH)(2)D-3] and its receptor, the...
INSULIN | 25-HYDROXYVITAMIN-D-3-1-ALPHA-HYDROXYLASE EXPRESSION | NUTRITION & DIETETICS | PROSTATE-CANCER | 1-ALPHA-HYDROXYLASE | CALCIUM | D DEFICIENCY | 25-HYDROXYVITAMIN D | 1,25-DIHYDROXYVITAMIN D-3 | D-RECEPTOR | FAILURE | Signal Transduction | Humans | Receptors, Calcitriol - physiology | Cholecalciferol - blood | Receptors, Calcitriol - metabolism | Nutrition Policy | Organ Specificity | Vitamin D Deficiency - physiopathology | Vitamin D - blood | Tissue Distribution | Receptors, Calcitriol - blood | Cholecalciferol - metabolism | Vitamin D - analogs & derivatives | Vitamin D - metabolism | Cholecalciferol - physiology | Vitamin D - physiology | Vitamin D Deficiency - metabolism | 24,25-Dihydroxyvitamin D 3 | Vitamin D deficiency | Care and treatment | Vitamin D | Growth | Calcifediol | Alfacalcidol | Research | Properties | Statistics | Steroid hormones
INSULIN | 25-HYDROXYVITAMIN-D-3-1-ALPHA-HYDROXYLASE EXPRESSION | NUTRITION & DIETETICS | PROSTATE-CANCER | 1-ALPHA-HYDROXYLASE | CALCIUM | D DEFICIENCY | 25-HYDROXYVITAMIN D | 1,25-DIHYDROXYVITAMIN D-3 | D-RECEPTOR | FAILURE | Signal Transduction | Humans | Receptors, Calcitriol - physiology | Cholecalciferol - blood | Receptors, Calcitriol - metabolism | Nutrition Policy | Organ Specificity | Vitamin D Deficiency - physiopathology | Vitamin D - blood | Tissue Distribution | Receptors, Calcitriol - blood | Cholecalciferol - metabolism | Vitamin D - analogs & derivatives | Vitamin D - metabolism | Cholecalciferol - physiology | Vitamin D - physiology | Vitamin D Deficiency - metabolism | 24,25-Dihydroxyvitamin D 3 | Vitamin D deficiency | Care and treatment | Vitamin D | Growth | Calcifediol | Alfacalcidol | Research | Properties | Statistics | Steroid hormones
Journal Article
Journal of the Science of Food and Agriculture, ISSN 0022-5142, 05/2014, Volume 94, Issue 7, pp. 1389 - 1396
BACKGROUND Vitamin D is an essential component of vertebrate nutrition, and epidemiological surveys confirm a chronic vitamin D insufficiency in the human...
eggs | laying hens | 25‐hydroxyvitamin D3 | vitamin D | vitamin D3 | Vitamin D | Laying hens | Eggs | CHOLECALCIFEROL | METABOLITES | FOOD SCIENCE & TECHNOLOGY | 25-hydroxyvitamin D3 | PREVENTION | 25-HYDROXYCHOLECALCIFEROL | PREVALENCE | OSTEOPOROSIS | LIQUID-CHROMATOGRAPHY | CALCIUM | AGRICULTURE, MULTIDISCIPLINARY | D INSUFFICIENCY | CHEMISTRY, APPLIED | YOLK | Eggs - analysis | Up-Regulation | Egg Yolk - chemistry | Nutritive Value | Humans | Functional Food - analysis | Cholecalciferol - analysis | Behavior, Animal | Cholecalciferol - administration & dosage | Calcifediol - adverse effects | Adult | Female | Cholecalciferol - adverse effects | Chickens - physiology | Child | Diet - veterinary | Calcifediol - administration & dosage | Calcifediol - analysis | Energy Intake | Oviparity | Animals | Cholecalciferol - metabolism | Animals, Inbred Strains | Calcifediol - metabolism | Recommended Dietary Allowances | Australia | Calcifediol | Alfacalcidol | Health
eggs | laying hens | 25‐hydroxyvitamin D3 | vitamin D | vitamin D3 | Vitamin D | Laying hens | Eggs | CHOLECALCIFEROL | METABOLITES | FOOD SCIENCE & TECHNOLOGY | 25-hydroxyvitamin D3 | PREVENTION | 25-HYDROXYCHOLECALCIFEROL | PREVALENCE | OSTEOPOROSIS | LIQUID-CHROMATOGRAPHY | CALCIUM | AGRICULTURE, MULTIDISCIPLINARY | D INSUFFICIENCY | CHEMISTRY, APPLIED | YOLK | Eggs - analysis | Up-Regulation | Egg Yolk - chemistry | Nutritive Value | Humans | Functional Food - analysis | Cholecalciferol - analysis | Behavior, Animal | Cholecalciferol - administration & dosage | Calcifediol - adverse effects | Adult | Female | Cholecalciferol - adverse effects | Chickens - physiology | Child | Diet - veterinary | Calcifediol - administration & dosage | Calcifediol - analysis | Energy Intake | Oviparity | Animals | Cholecalciferol - metabolism | Animals, Inbred Strains | Calcifediol - metabolism | Recommended Dietary Allowances | Australia | Calcifediol | Alfacalcidol | Health
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 07/2013, Volume 98, Issue 7, pp. 2709 - 2715
Context: We previously showed that a single high dose of oral (po) cholecalciferol (D3) sharply increases serum 25-hydroxyvitamin D [25(OH)D]. Objective: We...
SUPPLEMENTATION | WOMEN | HEALTHY-SUBJECTS | ENDOCRINOLOGY & METABOLISM | 25-HYDROXYVITAMIN D | PREVENTION | D-2 | FRACTURES | HYPOVITAMINOSIS D | VITAMIN-D DEFICIENCY | SERUM CALCIOTROPIC HORMONES | Humans | Middle Aged | Vitamin D Deficiency - drug therapy | Biological Availability | Ergocalciferols - therapeutic use | Male | Cholecalciferol - blood | Chromatography, High Pressure Liquid | Tandem Mass Spectrometry | Cholecalciferol - administration & dosage | Spectrometry, Mass, Electrospray Ionization | Vitamin D Deficiency - blood | Biotransformation | Cholecalciferol - therapeutic use | Radioimmunoassay | Female | Reproducibility of Results | Calcifediol - blood | Administration, Oral | Injections, Intramuscular | Cholecalciferol - pharmacokinetics | Vitamin D Deficiency - prevention & control | Ergocalciferols - blood | Ergocalciferols - pharmacokinetics | Ergocalciferols - administration & dosage | 25-Hydroxyvitamin D 2 - blood | Aged | 24,25-Dihydroxyvitamin D 3 - blood
SUPPLEMENTATION | WOMEN | HEALTHY-SUBJECTS | ENDOCRINOLOGY & METABOLISM | 25-HYDROXYVITAMIN D | PREVENTION | D-2 | FRACTURES | HYPOVITAMINOSIS D | VITAMIN-D DEFICIENCY | SERUM CALCIOTROPIC HORMONES | Humans | Middle Aged | Vitamin D Deficiency - drug therapy | Biological Availability | Ergocalciferols - therapeutic use | Male | Cholecalciferol - blood | Chromatography, High Pressure Liquid | Tandem Mass Spectrometry | Cholecalciferol - administration & dosage | Spectrometry, Mass, Electrospray Ionization | Vitamin D Deficiency - blood | Biotransformation | Cholecalciferol - therapeutic use | Radioimmunoassay | Female | Reproducibility of Results | Calcifediol - blood | Administration, Oral | Injections, Intramuscular | Cholecalciferol - pharmacokinetics | Vitamin D Deficiency - prevention & control | Ergocalciferols - blood | Ergocalciferols - pharmacokinetics | Ergocalciferols - administration & dosage | 25-Hydroxyvitamin D 2 - blood | Aged | 24,25-Dihydroxyvitamin D 3 - blood
Journal Article